Oruka Therapeutics

IPO

A new era for chronic skin diseases

Public · Menlo Park, United States · Founded 2024 · $205.0M raised

Employees
11–50
Founded
2024
Business Model
B2B
Total Funding
$205.0M
Last Round
$180.0M Private EquitySep 2025
Rounds
2
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Oruka Therapeutics is a clinical-stage biopharmaceutical company developing novel monoclonal antibodies designed to set a new standard for the treatment of chronic skin diseases. The company is advancing potentially best-in-class biologics — ORKA-001 and ORKA-002 — that aim to deliver higher rates of complete disease clearance in moderate-to-severe plaque psoriasis with as few as one or two doses per year. Founded by seasoned biopharma professionals, Oruka's name reflects its mission: derived from 'or' for 'skin' and 'arukah' for 'restoration.'

Summary

Oruka Therapeutics is a Healthcare company based in Menlo Park, United States, founded in 2024. It has raised $205.0M in total across 2 rounds, most recently a $180.0M Private Equity round in Sep 2025. Investors include Viking Global, Fairmount Funds and Blackstone.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPOApr 2026
$700.0M

Sign up to see all 3 events

Funding: Convertible Note through Private Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Oruka Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/oruka-therapeutics"><img src="https://indexed.vc/api/badge/company/oruka-therapeutics" alt="Oruka Therapeutics on Indexed.vc" width="260" height="76" /></a>